Halothane
|
CAS
151-67-7
|
CF3CHBrCl
|
RTECS
KH6550000
|
Synonyms & Trade Names
1-Bromo-1-chloro-2,2,2-trifluoroethane; 2-Bromo-2-chloro-1,1,1-trifluoroethane; 1,1,1-Trifluoro-2-bromo-2-chloroethane; 2,2,2-Trifluoro-1-bromo-1-chloroethane
|
DOT ID & Guide
|
Exposure
Limits
|
NIOSH REL*: C 2 ppm (16.2 mg/m3) [60-minute] [*Note: REL for exposure to waste anesthetic gas.]
|
|
OSHA PEL: none
|
IDLH
N.D.
See: IDLH INDEX
|
Conversion
1 ppm = 8.07 mg/m3
|
Physical Description
Clear, colorless liquid with a sweetish, pleasant odor. [inhalation anesthetic]
|
MW: 197.4
|
BP: 122°F
|
FRZ: -180°F
|
Sol: 0.3%
|
VP: 243 mmHg
|
IP: ?
|
|
Sp.Gr: 1.87
|
Fl.P: NA
|
UEL: NA
|
LEL: NA
|
|
|
Noncombustible Liquid
|
Incompatibilities & Reactivities
May attack rubber & some plastics; sensitive to light. [Note: Light causes decomposition. May be stabilized with 0.01% thymol.]
|
Measurement Methods
OSHA 29
See: NMAM or OSHA Methods |
Personal Protection & Sanitation (See protection)
Skin: Prevent skin contact
Eyes: Prevent eye contact
Wash skin: When contaminated
Remove: When wet or contaminated
Change: No recommendation
Provide: Eyewash
|
First Aid (See procedures)
Eye: Irrigate immediately
Skin: Soap wash promptly
Breathing: Respiratory support
Swallow: Medical attention immediately
|
Respirator Recommendations
Not available.
Important additional information about respirator selection
|
Exposure Routes
inhalation, skin absorption, ingestion, skin and/or eye contact
|
Symptoms
Irritation eyes, skin, respiratory system; confusion, drowsiness, dizziness, nausea, analgesia, anesthesia; cardiac arrhythmias; liver, kidney damage; decreased audio-visual performance; in animals: reproductive effects
|
Target Organs
Eyes, skin, respiratory system, cardiovascular system, central nervous system, liver, kidneys, reproductive system
|
|
See also: INTRODUCTION
See ICSC CARD: 0277 |
